4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-14-044720
Options or other derivatives
- Director acquired 150,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Yanai Shlomo Director | 2014-07-24 | Grant or award · Stock Options (Right to Buy) | +150,000 | 150,000 | D | ||
Loading xslF345X03/v384643_4.xml…